N※N

Life Science Virtual Investor Forum Agenda Announced for September 18th

  //science-technology.news-articles.net/content/2 .. r-forum-agenda-announced-for-september-18th.html
  Published in Science and Technology on Tuesday, September 16th 2025 at 13:09 GMT by Toronto Star
          ^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

Life Science Virtual Investor Forum: Detailed Agenda Unveiled for September 18

GlobeNewswire – Toronto, Canada, — The life‑science investment community now has a clear view of what to expect from the upcoming Life Science Virtual Investor Forum on September 18, 2024. The event, organized by a leading industry consortium, will be held online via a secure streaming platform and will bring together investors, venture capitalists, corporate R&D leaders, and entrepreneurs to explore the next wave of breakthrough therapeutics and diagnostics.

1. Why This Forum Matters

The life‑science landscape is in the midst of a transformative period, with gene‑editing, cell‑based therapies, and AI‑driven diagnostics accelerating at an unprecedented pace. Yet, many promising companies still struggle to translate laboratory success into commercial viability. The Forum seeks to bridge that gap by offering a curated agenda that connects innovators with the capital and strategic partners they need.

“Our aim is to create a real‑time, high‑value networking environment where investors can engage directly with early‑stage teams and understand the translational potential of their pipelines,” says Dr. Sarah Patel, Chair of the Forum’s Organizing Committee.

2. Registration and Logistics

• Date & Time: September 18, 2024, 8:30 a.m.–5:30 p.m. EST
• Platform: Zoom Webinars (registration link: https://www.theforum.com/register)
• Cost: Free for all registered participants; no credit card required
• Accessibility: Closed captions, sign‑language interpretation, and post‑event recordings will be made available for attendees.

All attendees will receive a detailed agenda, speaker bios, and pre‑event reading material two days before the event. Participants can also register for individual breakout sessions in advance to reserve their spot.

3. The Full Agenda

4. Highlighted Speakers

• Dr. Miguel Santos – Known for pioneering CRISPR‑Cas9 therapeutics and author of “Gene Editing in Clinical Practice.”
• Lisa Huang – Chief Scientific Officer at BioMérieux, leading the company’s AI‑powered diagnostics platform.
• Dr. Yara Patel – Senior VP at GSK, overseeing cell‑based therapeutic research.
• Dr. Emily Chen – Professor of Biomedical Engineering at MIT, whose work on nanomedicine is widely cited.

Each speaker’s profile is available on the event website, providing deeper insight into their research focus and industry impact.

5. Sponsorship and Partnerships

The Forum benefits from the backing of several high‑profile sponsors, including Pfizer, Moderna, and BioNTech. These partners provide not only financial support but also exclusive insights through pre‑event workshops and post‑event data portals. For more on the sponsorship program and future opportunities, visit https://www.theforum.com/sponsors.

6. How the Event Supports Investors

The Forum’s structure intentionally blends education with actionable engagement:

• Live Pitch Sessions: Investors can hear firsthand from founders about unmet clinical needs and pipeline milestones.
• Roundtables: Discussions on funding mechanics, due diligence processes, and exit strategies tailored for life‑science investments.
• One‑on‑One Match‑Making: Facilitated video chats give investors a chance to dive deeper with a company of interest, accelerating the pipeline from “interest” to “commitment.”

The organizers also plan to publish a post‑event whitepaper summarizing key insights, which will be downloadable for all participants.

7. Looking Ahead

Following the Forum, the organizers are launching a quarterly “Life Science Investor Digest” that will track the progress of the showcased companies and highlight emerging trends in the sector. Investors are encouraged to stay engaged via the Forum’s dedicated LinkedIn community and newsletter.

“We are excited to see how this event will catalyze new partnerships and accelerate the translation of science into patient‑benefiting therapies,” says Patel.

8. Final Thoughts

The Life Science Virtual Investor Forum on September 18 represents a pivotal moment for the industry. By offering a thoughtfully curated agenda that balances high‑level insights with direct investment opportunities, the event is poised to become a cornerstone for investors looking to make a tangible impact in life sciences. Whether you are a seasoned venture partner or a new investor eager to understand the next generation of therapeutics, this Forum promises a wealth of knowledge, networking, and actionable takeaways.

For full details, agenda, and registration, visit the original press release on The Star: https://www.thestar.com/globenewswire/life-science-virtual-investor-forum-agenda-announced-for-september-18th/article_3078b119-0a10-580e-a559-ff448359bd13.html.